Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

EMA Recommends Approval for Pfizer, Bristol-Myers’ Eliquis
Bloomberg
Friday, March 18, 2011 - 10:22am
tags:
EMA, Europe, Eliquis, Pfizer, blood thinners, Apixaban
Zimmer, Biomet, Nobel Said to Be Among Bidders for Astra Tech
Bloomberg
Friday, March 18, 2011 - 9:11am
tags:
Zimmer, Biomet, dental, Nobel Biocare, Astra Tech, M&A
No Desk, No Chair: Glaxo to Torture Staffers By Abolishing Personal Workspaces
BNET Pharma
Friday, March 18, 2011 - 9:09am
tags:
GSK
Quest to Buy Celera for $344 Million
TheStreet.com
Friday, March 18, 2011 - 9:04am
tags:
M&A, Celera, Quest Diagnostics
Vertex's Treatment for Cystic Fibrosis
Bloomberg Businessweek
Friday, March 18, 2011 - 9:03am
tags:
cystic fibrosis, Vertex Pharmaceuticals, VX-770
Actelion’s Hiring of Goldman May Lead to Sale, Vontobel Says
Bloomberg
Friday, March 18, 2011 - 9:02am
tags:
Actelion, M&A
[video] The Next Big Thing In Biotech: Bristol-Myers
TheStreet.com
Friday, March 18, 2011 - 9:01am
tags:
Bristol-Myers Squibb, skin cancer, Yervoy, ipilimumab
Taking a Bite Out of Amylin's Obesity Drug Potential
Motley Fool
Thursday, March 17, 2011 - 11:29pm
tags:
Amylin, obesity, pramlintide, metreleptin, Takeda
Rexahn: Recent Concerns Overshadowing a Robust Pipeline?
Seeking Alpha
Thursday, March 17, 2011 - 11:27pm
tags:
Rexahn
Lilly Claim Over Hospira’s Gemzar Copy to Be Reviewed By ITC
Bloomberg
Thursday, March 17, 2011 - 11:26pm
tags:
Eli Lilly, Gemzar, Hospira, generics
Analysts say current Medicare policy on anemia drugs is best scenario for Amgen
Yahoo/AP
Thursday, March 17, 2011 - 6:21pm
tags:
Medicare, anemia, Amgen, JNJ, Procrit, Aranesp, Epogen
Meet the Cash Kings of Pharma
Motley Fool
Thursday, March 17, 2011 - 6:20pm
tags:
Novartis, Sanofi, Bristol-Myers Squibb
Loss Narrows at Medivation
Yahoo/Zacks.com
Thursday, March 17, 2011 - 6:19pm
tags:
earnings, Medivation
Big Pharma and the Value of the Umbrella Brand
Fast Company
Thursday, March 17, 2011 - 11:28am
tags:
Big Pharma, branding
Interview: Pfizer vaccine unit eyes adults, infectious disease
Fierce Biotech
Thursday, March 17, 2011 - 11:11am
tags:
vaccines, Pfizer
Idenix: Not Worth the Wait
Seeking Alpha
Thursday, March 17, 2011 - 11:01am
tags:
Indenix, hepatitis C, Pharmasset, HCV
Genfit signs drug deal with Sanofi, shares surge
Reuters
Thursday, March 17, 2011 - 10:54am
tags:
Genfit, Sanofi, drug discovery, metabolic disorders
New study shows ten states to carry more than half of U.S. diabetes population and costs through 2025
Yahoo
Thursday, March 17, 2011 - 10:51am
tags:
diabetes
SuperGen: Flush With Cash, But Drug Pipeline Is Anemic
Seeking Alpha
Thursday, March 17, 2011 - 10:48am
tags:
Supergen, Dacogen
Pfizer Baby Food Unit Gets $6.8 Billion in Mead Model: Real M&A
Bloomberg
Thursday, March 17, 2011 - 10:47am
tags:
M&A, Pfizer, nutrition

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.